(Q41529391)

2 October 2017

1 reference

title

Estrogen and progestin components of oral contraceptives: relationship to vascular disease (English)

1 reference

2 October 2017

B R Carr

1

1 reference

2 October 2017

H Ory

series ordinal

2

1 reference

2 October 2017

publication date

1 May 1997

1 reference

2 October 2017

1 reference

2 October 2017

volume

55

1 reference

2 October 2017

issue

5

1 reference

2 October 2017

page(s)

267-272

1 reference

Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Oral contraceptive use and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke Cigarettes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Myocardial infarction in users of low-dose oral contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Risk of acute myocardial infarction and low-dose combined oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Oral contraceptives and stroke: findings in a large prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Stroke in users of low-dose oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Fatal stroke and use of oral contraceptives: findings from a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Risk factors for fatal venous thromboembolism in young women: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Finland from 1975 to 1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Selective prescribing of third generation oral contraceptives (OCs)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

Oral contraceptives and venous thromboembolism: findings in a large prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900029-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-7824(97)00029-2

1 reference

release_34h3b37rqvcuxanjtgvegb33xi

2 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/34h3b37rqvcuxanjtgvegb33xi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference